Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
01/11/2006 | CN1720234A Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives |
01/11/2006 | CN1720233A Pesticidal sulphonylaminopyrazoles |
01/11/2006 | CN1720231A Substituted dihydrophenanthridinesulfonamides |
01/11/2006 | CN1720225A N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
01/11/2006 | CN1720224A Vasculostatic agents and methods of use thereof |
01/11/2006 | CN1720047A PgD2 receptor antagonists for the treatment of inflammatory diseases |
01/11/2006 | CN1720045A Methods of using and compositions comprising immunomudulatory compounds for the treatment and management of myeloproliferative diseases |
01/11/2006 | CN1720043A Non-nucleoside reverse transcriptase inhibitors |
01/11/2006 | CN1719974A Pesticidal 5- (acylamino) pyrazole derivatives |
01/11/2006 | CN1235899C Improved process for preparing benzimidazole-type compounds |
01/10/2006 | US6984735 Reacting a dihalaromatic compound with sulfoxide |
01/10/2006 | US6984652 useful for the treatment or prophylaxis of bacterial infections in mammals |
01/10/2006 | US6984651 Piperidine amides as modulators of chemokine receptor activity |
01/10/2006 | US6984649 Pyridine derivatives |
01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
01/10/2006 | US6984643 2,5-substituted pyrimidine derivatives-CCR-3 receptor antagonists |
01/10/2006 | US6984642 for treating cardiovascular disorders, for example for the acute and chronic treatment of ischaemic disorders |
01/10/2006 | US6984639 such as (2S)-3,3-dimethyl-1-[2-(5-phenylpentanoyl) pyrrolidinyl]pentane-1,2-dione which has affinity for immunophilin; for treatment of neurological disorders/neurodegenerative diseases; nerve growth factors; FK binding proteins |
01/10/2006 | US6984637 Cyclic amine derivatives-CCR-3 receptor antagonists |
01/10/2006 | CA2364906C 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists |
01/10/2006 | CA2364178C N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
01/10/2006 | CA2223918C Pyrrole derivatives and medicinal composition |
01/10/2006 | CA2214033C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent |
01/10/2006 | CA2184612C Novel aryl n-alkylacridancarboxylate derivatives useful for chemiluminescent detection |
01/10/2006 | CA2129990C Benzodiazepin derivatives useful as cck-receptor antagonists |
01/05/2006 | WO2006002236A1 N- (1- (1-benzyl -4-phenyl-1h-imidazol-2-yl) -2,2-dymethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
01/05/2006 | WO2006001751A1 Chemical compounds i |
01/05/2006 | WO2006001750A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
01/05/2006 | WO2006000759A1 Substituted diketopiperazines as oxytocin antagonists |
01/05/2006 | WO2006000399A1 Novel compounds |
01/05/2006 | WO2006000371A2 Pyrimidine derivatives as 11beta-hsd1 inhibitors |
01/05/2006 | WO2006000358A1 2, 4, 5, 6-substituted pyrimidines, method for the production and use thereof for combating parasitic fungi |
01/05/2006 | WO2006000354A1 Novel imidazoles and triazoles, the production thereof, and the use of the same as medicaments |
01/05/2006 | WO2006000353A1 Method for producing 4-(benzimidazolylmethylamino)-benzamidines |
01/05/2006 | WO2006000350A2 Cosmetic compositions containing protein hydrolysates |
01/05/2006 | WO2005113553A3 Azinyl imidazoazine and azinyl carboxamide |
01/05/2006 | WO2005100352A8 Selected cgrp-antagonists, their preparation processes and their use as medicaments |
01/05/2006 | WO2005099709A3 Bicyclic heterocycles useful as serine protease inhibitors |
01/05/2006 | WO2005085194A3 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors |
01/05/2006 | WO2005059107A3 Chemokine receptor binding compounds |
01/05/2006 | WO2004080976A8 Phthalazinone derivatives |
01/05/2006 | US20060004075 Substituted aryl amides as IP antagonists |
01/05/2006 | US20060004074 e.g. 1-(but-2-ynyl)-2-(3-amino-piperidin-1-yl)-5-(naphth-1-ylmethylaminocarbonyl)-1H-imidazole; dipeptidylpeptidase-IV inhibitor; antidiabetic, anticarcinogenic, antiinflammatory agent; autoimmune, neurodegenerative diseases; |
01/05/2006 | US20060004069 Agent for preventing or treating neuropathy |
01/05/2006 | US20060004064 Condensation of substituted diaminobenzene with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)phenylamino]acetic acid; then hydrogenation; carbonylation with an alkylhalogen formate, in the presence of hexyl chloroformate; 4-(benzimidazol-2-ylmethylamino)benzamidine; prevention of deep vein thrombosis |
01/05/2006 | US20060004059 Substituted heterocycles for the treatment of diabetes and other diseases |
01/05/2006 | US20060004057 New compounds |
01/05/2006 | US20060004056 Di-aryl-substituted-ethan pyridone pde4 inhibitors |
01/05/2006 | US20060004055 Derivative of 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(piperidine-1-yl)-1H-pyrazole-3-carboxamide, the preparation and therapeutic use thereof |
01/05/2006 | US20060004054 Administering 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline before or at the time angioplasty, coronary by-pass grafting or stent implantation |
01/05/2006 | US20060004047 Piperidine derivatives as ccr5 inhibitors |
01/05/2006 | US20060004044 3-glyoxylamideindoles for treating cancer |
01/05/2006 | US20060004043 Indazole compounds and methods of use thereof |
01/05/2006 | US20060004041 Compounds for treatment of neurodegenerative diseases |
01/05/2006 | US20060004040 Method for the prevention and/or treatment of atherosclerosis |
01/05/2006 | US20060004033 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
01/05/2006 | US20060004030 Asthma, antiallergens; rheumatoid arthritis and atherosclerosis; anticarcinogenic agents; 2-(Benzylthio)-6-{[(1R)-2-hydroxy-1-methylethyl]amino}-4-pyrimidinol |
01/05/2006 | US20060004029 Nitrogen-containing aromatic derivatives |
01/05/2006 | US20060004022 4-, 5-, 6- And 7-indole derivatives useful for the treatment of CNS disorders |
01/05/2006 | US20060004021 Ethyl 4-{[2-(3-chlorophenyl)-2H-tetrazol-5-yl]methyl}piperazine-1-carboxylate; gastrointestinal disorders, chronic and acute pain, psychiatric and neurological disorders; obesity |
01/05/2006 | US20060004017 Quinazoline derivatives as angiogenesis inhibitors |
01/05/2006 | US20060004015 Fibrotic disorders; disorders characterized by harmful buildup of collagen and/or by excessive lysyl oxidase enzymatic activity |
01/05/2006 | US20060004013 Cinnamide compound |
01/05/2006 | US20060004010 Ccr4 antagonist and medical use thereof |
01/05/2006 | US20060004009 Ethylenediamine derivatives |
01/05/2006 | US20060004005 Triazines derivatives as cell adhesion inhibitors |
01/05/2006 | US20060004004 Novel gamma secretase inhibitors |
01/05/2006 | US20060004000 N-aryl-5-substituted-3-yl-1H-indazole-3-carboxamides; amidation of the 1-protected-1H-indazole-3-carboxylic acid, deblocking; hypotensive agents |
01/05/2006 | US20060003993 Benzotriazepnes as gastrin and cholecystokinin receptor ligands |
01/05/2006 | US20060003926 Anticancer, antitumor agents; mixture of metal, drug, peptide and carriers |
01/05/2006 | DE102004028973A1 Substituierte Tetrahydro-2H-isochinolin-1-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted tetrahydro-2H-isoquinolin-1-one derivatives, to processes for their preparation and their use as a medicament |
01/05/2006 | DE102004028751A1 New 4-heterocyclyl-1-acyl-piperidine derivatives, useful e.g. for treating headache, diabetes and cardiovascular disease, are antagonists of calcitonin-gene related peptide |
01/05/2006 | CA2810655A1 Modulators of atp-binding cassette transporters |
01/05/2006 | CA2572136A1 Novel imidazoles and triazoles, the production thereof, and the use of the same as medicaments |
01/05/2006 | CA2572135A1 Sulfonamide compound |
01/05/2006 | CA2571949A1 Modulators of atp-binding cassette transporters |
01/05/2006 | CA2571712A1 Novel indazole carboxamides and their use |
01/05/2006 | CA2571527A1 Piperazinediones as oxytocin receptor antagonists |
01/05/2006 | CA2571443A1 Pyridyl piperazines for the treatment of cns disorders |
01/05/2006 | CA2571087A1 Novel piperidine derivates as modulators of chemokine receptor ccr5 |
01/05/2006 | CA2571058A1 Cannabinoid receptor ligands |
01/05/2006 | CA2571002A1 N-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dimethylpropyl)benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
01/05/2006 | CA2570873A1 Pyrimidine urea derivatives as kinase inhibitors |
01/05/2006 | CA2570673A1 Compounds and methods for treating dyslipidemia |
01/05/2006 | CA2570619A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
01/05/2006 | CA2570499A1 Method for producing 4-(benzimidazolylmethylamino)-benzamidines |
01/05/2006 | CA2567851A1 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity |
01/04/2006 | EP1612208A2 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
01/04/2006 | EP1612204A1 Hydrazone derivative |
01/04/2006 | EP1611902A1 Preventive and/or therapeutic agent for neuropathic pain |
01/04/2006 | EP1611901A1 Preventive or remedy for teeth grinding |
01/04/2006 | EP1611127A2 4-substitued quinolein derivatives with antimicrobial activity |
01/04/2006 | EP1611125A1 Heteroaryl substituted pyrolls useful as inhibitors of protein kinases |
01/04/2006 | EP1611124A1 Piperidine derivatives for the treatment of chemokine or h1 mediated disease state |
01/04/2006 | EP1611123A2 Tie-2 modulators and methods of use |
01/04/2006 | EP1611122A1 Substituted pyrazole compounds |
01/04/2006 | EP1611121A1 Pyridazinone derivatives as cdk2-inhibitors |
01/04/2006 | EP1611097A1 Indole derivatives useful for the treatment of deseases |
01/04/2006 | EP1611096A2 Benzamide modulators of metabotropic glutamate receptors |